{"title":"Subsequent pregnancy outcomes of excisional surgery vs conservative surgery for cesarean scar pregnancy.","authors":"Ning Wang, Feng Qi, Jianwei Zhou, Xiaocen Niu, Xingmiao Li, Mengjia Yu, Yanan Yang, Xuelu Zhu, Xiuxiu Jiang","doi":"10.1016/j.ajogmf.2025.101776","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recurrent cesarean scar pregnancy (CSP) presents a significant clinical challenge for gynecologists. A thinner residual myometrium is an independent risk factor for CSP recurrence. There is limited evidence regarding which treatment modalities effectively reduce the risk of CSP recurrence.</p><p><strong>Objective: </strong>This study compared subsequent pregnancy outcomes between excisional and conservative surgical treatments in CSP patients with a thin residual myometrium.</p><p><strong>Study design: </strong>This was a multicenter retrospective observational cohort study of CSP patients hospitalized in China. The participants were recruited from January 1, 2019, to December 31, 2021, and data on pregnancy outcomes were collected up to January 31, 2025. Data were collected from CSP patients with a residual myometrium thickness ≤3 mm who underwent surgical management through either excisional surgery (ES) (CSP excision and hysterotomy closure) or conservative surgery (CS) (vacuum aspiration and surgical hysteroscopy). Patients with a residual myometrium >3 mm, those with a gestational age greater than 12 weeks, those with incomplete medical records or follow-up data, those who did not undergo surgical management, and those without fertility requirements were excluded. Data were obtained from the health system's electronic health records and telephone follow-up. The primary outcome was the subsequent pregnancy outcome of CSP. Survival analysis was performed to evaluate the risk of CSP recurrence.</p><p><strong>Results: </strong>Among the 464 CSP patients (median [interquartile range] age, 34.0 [31.0-37.0] years), 32 (6.9%) underwent ES, and 432 (93.1%) underwent CS. The pregnancy rate in the excisional group was significantly greater than that in the conservative group (20 [62.5%, 95% confidence interval (95% CI): 45.7%-79.3%] vs 130 [30.1%, 95% CI: 25.8%-34.4%], P<.001). The CSP recurrence rate in the excisional group was significantly lower than that in the conservative group (1 [5.0%, 95% CI: 0%-14.6%] vs 41 [31.5%, 95% CI: 23.6%-39.5%], P=.014). After the postsurgical pregnancy interval were considered, the CSP recurrence rate in the excisional group was lower than that in the conservative group according to time-dependent Cox regression analysis (hazard ratio, 0.34; 95% CI: 0.14-0.82; P=.01).</p><p><strong>Conclusion: </strong>For CSP patients with a thinner residual myometrium, ES improves the pregnancy rate while effectively reducing the risk of CSP recurrence.</p>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101776"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Obstetrics & Gynecology Mfm","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajogmf.2025.101776","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Recurrent cesarean scar pregnancy (CSP) presents a significant clinical challenge for gynecologists. A thinner residual myometrium is an independent risk factor for CSP recurrence. There is limited evidence regarding which treatment modalities effectively reduce the risk of CSP recurrence.
Objective: This study compared subsequent pregnancy outcomes between excisional and conservative surgical treatments in CSP patients with a thin residual myometrium.
Study design: This was a multicenter retrospective observational cohort study of CSP patients hospitalized in China. The participants were recruited from January 1, 2019, to December 31, 2021, and data on pregnancy outcomes were collected up to January 31, 2025. Data were collected from CSP patients with a residual myometrium thickness ≤3 mm who underwent surgical management through either excisional surgery (ES) (CSP excision and hysterotomy closure) or conservative surgery (CS) (vacuum aspiration and surgical hysteroscopy). Patients with a residual myometrium >3 mm, those with a gestational age greater than 12 weeks, those with incomplete medical records or follow-up data, those who did not undergo surgical management, and those without fertility requirements were excluded. Data were obtained from the health system's electronic health records and telephone follow-up. The primary outcome was the subsequent pregnancy outcome of CSP. Survival analysis was performed to evaluate the risk of CSP recurrence.
Results: Among the 464 CSP patients (median [interquartile range] age, 34.0 [31.0-37.0] years), 32 (6.9%) underwent ES, and 432 (93.1%) underwent CS. The pregnancy rate in the excisional group was significantly greater than that in the conservative group (20 [62.5%, 95% confidence interval (95% CI): 45.7%-79.3%] vs 130 [30.1%, 95% CI: 25.8%-34.4%], P<.001). The CSP recurrence rate in the excisional group was significantly lower than that in the conservative group (1 [5.0%, 95% CI: 0%-14.6%] vs 41 [31.5%, 95% CI: 23.6%-39.5%], P=.014). After the postsurgical pregnancy interval were considered, the CSP recurrence rate in the excisional group was lower than that in the conservative group according to time-dependent Cox regression analysis (hazard ratio, 0.34; 95% CI: 0.14-0.82; P=.01).
Conclusion: For CSP patients with a thinner residual myometrium, ES improves the pregnancy rate while effectively reducing the risk of CSP recurrence.
期刊介绍:
The American Journal of Obstetrics and Gynecology (AJOG) is a highly esteemed publication with two companion titles. One of these is the American Journal of Obstetrics and Gynecology Maternal-Fetal Medicine (AJOG MFM), which is dedicated to the latest research in the field of maternal-fetal medicine, specifically concerning high-risk pregnancies. The journal encompasses a wide range of topics, including:
Maternal Complications: It addresses significant studies that have the potential to change clinical practice regarding complications faced by pregnant women.
Fetal Complications: The journal covers prenatal diagnosis, ultrasound, and genetic issues related to the fetus, providing insights into the management and care of fetal health.
Prenatal Care: It discusses the best practices in prenatal care to ensure the health and well-being of both the mother and the unborn child.
Intrapartum Care: It provides guidance on the care provided during the childbirth process, which is critical for the safety of both mother and baby.
Postpartum Issues: The journal also tackles issues that arise after childbirth, focusing on the postpartum period and its implications for maternal health. AJOG MFM serves as a reliable forum for peer-reviewed research, with a preference for randomized trials and meta-analyses. The goal is to equip researchers and clinicians with the most current information and evidence-based strategies to effectively manage high-risk pregnancies and to provide the best possible care for mothers and their unborn children.